How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Brain Cancer Imaging Market
- By Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Ultrasound Imaging
- By Contrast Agent Type: Gadolinium-based Contrast Agents, Iron Oxide Nanoparticles, Fluorodeoxyglucose (FDG), Iodinated Contrast Agents, Radiolabeled Tracers
- By Application: Diagnosis and Detection, Treatment Planning, Surgical Navigation, Therapy Monitoring, Recurrence Detection
- By End User: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Research Institutes, Specialty Clinics
- By Technology: Functional MRI (fMRI), Diffusion Tensor Imaging (DTI), Magnetic Resonance Spectroscopy (MRS), Hybrid PET/MRI Systems, Artificial Intelligence-based Imaging Analysis
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Magnetic Resonance Imaging (MRI) leads By Imaging Modality at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Brain Cancer Imaging Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Imaging Modality 5
Contrast Agent Type 5
Application 5
End User 5
Technology 5
Companies profiled
Siemens Healthineers
GE Healthcare
Philips Healthcare
Canon Medical Systems Corporation
Hitachi Medical Corporation
Fujifilm Holdings Corporation
Samsung Medison
Bracco Imaging S.p.A.
Bayer AG (Radiology division)
Canon Inc. (Medical Imaging division)
Hologic Inc.
Shimadzu Corporation
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Canon Medical Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Hitachi Medical Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Fujifilm Holdings Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Samsung Medison
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Bracco Imaging S.p.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Bayer AG (Radiology division)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Canon Inc. (Medical Imaging division)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Hologic Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Shimadzu Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Carestream Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Esaote S.p.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Neusoft Medical Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,358M by 2033 · 7.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Magnetic Resonance Imaging (MRI)47.5
- Computed Tomography (CT)11.7
- Positron Emission Tomography (PET)13.8
- Single Photon Emission Computed Tomography (SPECT)9.5
- Ultrasound Imaging17.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,773M → $2,827M · 6.0%
Europe$1,236M → $2,324M · 8.2%
Asia Pacific$1,128M → $1,964M · 7.2%
Latin America$698.4M → $1,236M · 7.4%
Middle East and Africa$537.2M → $854.2M · 6.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.142026
7.142027
7.162028
7.182029
7.192030
7.192031
7.202032
7.212033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Siemens Healthineers22.3
- GE Healthcare25.3
- Philips Healthcare8.7
- Canon Medical Systems Corporation5.7
- Hitachi Medical Corporation5.5
- Fujifilm Holdings Corporation4.4
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Imaging Modality14.4%
Contrast Agent Type29.6%
Application19.8%
End User19.3%
Technology16.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.7
- Europe25.2
- Asia Pacific21.3
- Latin America13.4
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Siemens Healthineers | 73 | 90 | 83 | 74 | 75 | 96 | 82 |
| GE Healthcare | 83 | 82 | 68 | 82 | 92 | 71 | 80 |
| Philips Healthcare | 74 | 79 | 69 | 84 | 70 | 69 | 74 |
| Canon Medical Systems Corporation | 67 | 62 | 59 | 79 | 64 | 71 | 67 |
| Hitachi Medical Corporation | 71 | 54 | 53 | 76 | 75 | 60 | 65 |
| Fujifilm Holdings Corporation | 70 | 55 | 47 | 70 | 49 | 66 | 60 |
| Samsung Medison | 55 | 54 | 43 | 64 | 60 | 63 | 57 |
| Bracco Imaging S.p.A. | 46 | 51 | 38 | 57 | 48 | 57 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Siemens Healthineers
- GE Healthcare
- Philips Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Siemens Healthineers | ✓ | ◐ | ✓ | ◐ | − | ◐ |
| GE Healthcare | ✓ | ✓ | − | ✓ | ✓ | ◐ |
| Philips Healthcare | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Canon Medical Systems Corporation | ◐ | ◐ | ◐ | ◐ | − | ✓ |
| Hitachi Medical Corporation | − | ◐ | − | ✓ | ◐ | ◐ |
| Fujifilm Holdings Corporation | ◐ | − | − | − | ◐ | − |
| Samsung Medison | ◐ | ◐ | − | − | ◐ | ◐ |
| Bracco Imaging S.p.A. | ◐ | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Siemens Healthineers82
2GE Healthcare80
3Philips Healthcare74
4Canon Medical Systems Corporation67
5Hitachi Medical Corporation65
6Fujifilm Holdings Corporation60
7Samsung Medison57
8Bracco Imaging S.p.A.50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Siemens HealthineersGE Healthcare
Challenger2
Strong scale, closing on the leaders.
Philips HealthcareCanon Medical Systems Corporation
Contender3
Focused players with pockets of strength.
Hitachi Medical CorporationFujifilm Holdings CorporationSamsung Medison
Niche1
Specialists in a single segment or region.
Bracco Imaging S.p.A.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Imaging Modality in North America, then scale across Brain Cancer Imaging Market — a $166M beachhead inside a $3.06B market.
Beachhead (SOM)$166Mobtainable near-term
Serviceable (SAM)$1.14Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Magnetic Resonance Imaging (MRI)
Best fit — highest urgency & budget in Imaging Modality.
Economic buyer81 fit
Computed Tomography (CT)
Strong fit — clear ROI and a fast path to value.
End user67 fit
Positron Emission Tomography (PET)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Imaging Modality in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Contrast Agent Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve19%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Imaging Modality leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Brain Cancer Imaging Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified21%
Evaluation12%
Closed-won6%
$16.9KCAC
$92KLTV
5.4:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Brain Cancer Imaging Market is a durable-growth opportunity — $6.50B by 2033, compounding at 9.1%.
TAM · 2025$3.23Btoday
TAM · 2033$6.50Bforecast
CAGR9.1%2027–2033
Cumulative$42.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.50BTotal addressable market
SAM$2.67BServiceable available market
SOM$433MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.1% CAGR
Demand compounds through 2033, outpacing GDP across Imaging Modality.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Imaging Modality moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.50BLarge & growingTAM by 2033 at 9.1% CAGR
$2.67BServiceable nowreachable with today’s model
$433MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.07BBear5.9% CAGR
$6.50BBase9.1% CAGR
$8.32BBull12.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Contrast Agent Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Brain Cancer Imaging Market — a $1.79B market by 2033. Plan: grow share from 8.8% to 15.3%.
Market size · 2033$1.79Btotal addressable
Market CAGR5.1%2027–2033
Target share15.3%from 8.8% today
Revenue ambition$274Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.8% | 15.3% | On track |
| Revenue | $148M | $274M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 37.6% | 41.4% | At risk |
| Customer retention | 87.8% | 96.6% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Imaging Modality
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Contrast Agent Type capability
A defensible second engine — invest in Contrast Agent Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Imaging Modality share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Contrast Agent Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $37M capacity & capability investment
- Greenlight bolt-on M&A in Contrast Agent Type
- Authorise North America expansion plan
- Fund R&D program for Imaging Modality leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Brain Cancer Imaging Market conversation — a $2.03B market you can size, segment and defend in minutes.
Market size · 2033$2.03Btotal opportunity
Growth9.2%CAGR to 2033
Addressable buyers1,586+accounts in scope
Typical ROI5.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Imaging Modality
Goal Grow share in Imaging Modality
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.1×return on cost, year one
< 3 mopayback period
$56K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Siemens HealthineersGE HealthcarePhilips HealthcareCanon Medical Systems CorporationHitachi Medical CorporationFujifilm Holdings CorporationSamsung MedisonBracco Imaging S.p.A.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Brain Cancer Imaging Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Brain Cancer Imaging Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Brain Computer Interfaces (BCI) Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBrain Cotton Film Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportBrain Electrical Activity Mapping Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportBrain Fingerprint Technology Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportBrain Health Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportBrain Health Supplement Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportBrain Imaging Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBrain Implant Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBrain Injection Hammer Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBrain Machine Interface Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBrain Mapping Instrument Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportBrain Mint Market
Market size, share, segmentation and regional forecast.
$421M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.